1. Beijing Tide Pharmaceutical Co., Ltd. (12 from 17 patents)

2. Peking University (1 from 611 patents)

3. Beijing Baidu Netcom Science Technology Co., Ltd (1 from 452 patents)

4. Beijing University of Chemical Tehcnology (1 from 86 patents)

5. Beijing Aeronautical Science & Technology Research Institute, Commercial Aircraft Corporation of China (1 patent)

1. 12485108 - Method for treating fatty liver disease and/or steatohepatitis

2. 12459917 - Salt of diaminopyrimidine compounds, and solid form thereof, preparation method therefor and use thereof

3. 12379819 - Method and apparatus for adjusting perspective of direction indicator, electronic device, and storage medium

4. 12365665 - Solid form of diaminopyrimidine compound or hydrate thereof, preparation method therefor, and application thereof

5. 11939578 - Double-stranded RNA molecule targeting CKIP-1 and use thereof

6. 11938222 - Pregabalin sustained release composition and method for preparing the same

7. 11919918 - P2X3 andor P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof

8. 11905274 - Receptor inhibitors, pharmaceutical compositions comprising the same and use thereof

9. 11691138 - Cu/MMgOinterfacial catalyst for selective alkyne hydrogenation and its preparation method

10. 11414444 - P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof

11. 11390609 - Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereof

12. 11155819 - Double-stranded RNA molecule targeting CKIP-1 and use thereof

13. 10329282 - Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereof

14. 10323023 - Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereof

15. 7465453 - Polypeptide fragments of CKLF1